CXCR4 receptor expression is required for the retention of granulocyte precursors and mature neutrophils within the bone marrow, and disruption of the SDF-1/CXCR4 axis in the bone marrow results in the mobilization of myeloid lineage cells to the peripheral circulation. We report that G-CSF downregulates CXCR4 expression in bone marrowderived murine and human myeloid lineage cells. When exposed to G-CSF, murine
Introduction
Neutrophil release from the bone marrow is a highly regulated and dynamic process that ensures the maintenance of homeostatic levels of peripheral neutrophils. Although the mechanisms underlying this process are incompletely defined, compelling evidence from gene targeting studies and other observations indicates that the chemokine receptor CXCR4 and its unique ligand SDF-1 play a critical role in the retention of hematopoietic cells within the bone marrow and their mobilization to the peripheral circulation 1 .
When CXCR4-deficient hematopoietic cells were injected into lethally irradiated recipient mice, the reconstituted marrows revealed the presence of the more immature myeloid lineage cells but the more mature myeloid elements were noticeably reduced, likely a consequence of defective retention and premature release of the more mature, CXCR-4 negative, myeloid cells into the bloodstream 2 . Patients with WHIM (warts, hypogammaglobulinemia, recurrent bacterial infections, and "myelokathexis") syndrome, a genetic disorder characterized by heterozygous C-terminal truncations of CXCR4, are neutropenic, in spite of having normal neutrophils in the bone marrow 3, 4 , likely a consequence of defective neutrophil mobilization linked to a "gain of function" of the mutant CXCR4, with increased CXCR4 responsiveness to bone marrow SDF-1 [3] [4] [5] .
AMD3100, a drug that selectively blocks CXCR4 signaling, and methionine-SDF-1β, a mutant chemokine that binds CXCR4 and induces prolonged down-regulation of surface CXCR4 expression, promote the mobilization of neutrophils and hematopoietic progenitor cells to the peripheral blood 6, 7 .
G-CSF, the principal cytokine regulating the proliferation and differentiation of myeloid progenitors, is a potent inducer of the release of neutrophils, immature myeloid
For personal use only. on . by guest www.bloodjournal.org From lineage cells, and hematopoietic progenitor cells from the bone marrow into the peripheral blood [8] [9] [10] [11] . Recently, a number of studies have provided evidence that modulation of CXCR4/SDF-1-derived retention signals contributes to G-CSF-induced mobilization of bone marrow hematopoietic progenitor cells, but the underlying mechanisms are not clear [12] [13] [14] [15] [16] . Much attention has focused on the role of enzymatic cleavage of SDF-1. Following G-CSF administration, the marrow microenvironment is rich in proteolytic enzymes released by neutrophils, including Metalloproteinase-9
(MMP-9), neutrophil elastase and cathepsin G 17 . MMP-9, neutrophil elastase and cathepsin G can cleave and functionally inactivate SDF-1 [18] [19] [20] . A study in MMP-9-deficient mice detected defective G-CSF-induced mobilization of hematopoietic progenitor cells 21 . Treatment with an inhibitor of neutrophil elastase reduced, in part, the mobilization of hematopoietic progenitor cells induced by G-CSF 13 . However, the mobilization of hematopoietic progenitor cells was normal in mice deficient of either MMP-9 or neutrophil elastase plus cathepsin G, suggesting either a contribution by different enzymes or the occurrence of alternative pathways for G-CSF-induced mobilization of hematopoietic progenitor cells 16 . Recently, it was reported that G-CSF reduces SDF-1 synthesis in bone marrow and that reduced SDF-1 in the bone marrow correlates with stem cell mobilization 22 .
In this study, we have studied G-CSF regulation of CXCR4 expression in bone marrow myeloid lineage cells. We report that G-CSF significantly reduces levels of CXCR4 in bone marrow-derived primary myeloid lineage and identify downregulation of CXCR4 expression as an important mechanism for myeloid cell mobilization by G-CSF.
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Methods
Preparation of murine and human bone marrow cells. All animal experiments were performed according to NIH guidelines for the care and handling of mice. Bone marrow cells obtained by flushing femurs and tibias of mice (C57BL/6NCr, female, 6-10 week old, The Jackson Laboratory, Bar Harbor, ME) were cultures in DMEM culture medium with 10% fetal bovine serum (FBS, Difco Laboratories, Detroit, MI). Gr1 Briefly, bone marrow cells were loaded onto the upper well layered with a 3μ pore polycarbonate membrane (Transwell, Costar, Boston, MA). The lower chamber was supplemented with 0.6 mL DMEM with or without 100 ng/mL SDF-1 (R&D Systems).
After 2h incubation, all cells in the lower chamber were counted, stained with APC- International, Two Rivers, WI). After bocking (5% milk), membranes were incubated overnight with anti-mouse CXCR4 mAb (rat anti-mouse 2B11, BD Biosciences).
Bands were visualized using horseradish peroxidase-conjugated goat anti-rat antibody (Santa Cruz Biotechnology, Santa Cruz, CA), followed by enhanced chemioluminescence detection system (ECL, Amersham Biosciences, Little Chalfont, Buckinghamshire, UK).
Blots were stripped and probed with goat antibodies to actin (Santa Cruz Biotechnology). Mobilization of hematopoietic cells in mice. C57BL/6NCr, female mice, 6-10 week-old (The Jackson Laboratory, Bar Harbor, ME) were treated i.p. with 5 μg human G-CSF (Filgrastim, Amgen Inc, Thousand Oaks, CA) daily for 5 days. Control mice were observed untreated or received a daily i.p. injection of PBS containing 2% human albumin for 5 days. On day 6, mice were sacrificed, and peripheral blood, spleens, 9 femurs and tibias were collected. Bone marrow unfractionated cells were obtained from femurs and tibias and Gr1 + cells purified as described above.
Statistics. Results are presented as mean ± SEM (standard error of the mean).
Comparisons were carried out using Student's T test or Mann-Whitney U test, with P values <0.05 considered significant.
Results

G-CSF reduces surface CXCR4 expression in bone marrow myeloid cells.
Unfractionated bone marrow cells from mouse tibias and femurs (4-6 weeks-old C57 BL/6 mice) were incubated (1x10 6 cells/mL in DMEM medium supplemented with 10% FBS) at 37°C for 6h with or without G-CSF (0.1, 10 and 100 ng/mL). G-CSF dosedependently reduced surface levels of CXCR4 in Gr1 + cells (Fig. 1A) For personal use only. on . by guest www.bloodjournal.org From (100 ng/mL 37°C, 2h) reduced surface CXCR4 on these cells (not shown). We measured SDF-1 levels in culture supernatants of unfractionated bone marrow cells incubated (1x10 6 cell/mL) for 18h with or without G-CSF (100 ng/mL) and found them to be undetectable (<300 pg/mL) as measured by a specific ELISA (not shown).
Kinetic analysis showed that G-CSF (100 ng/mL, 18h) reduces surface CXCR4 expression in bone marrow Gr1 + cells after 2h incubation and continuing for 18h (Fig.   1C ). This effect was seen consistently (Fig. 1D) . Notably, surface CXCR4 levels are low in Gr1 + cells immediately after procurement from the bones, but progressively increase during 18h incubation at 37°C in medium alone (Fig. 1C) .
We tested whether G-CSF can reduce surface CXCR4 in Gr1 + cells that already express high levels surface CXCR4. Unfractionated bone marrow cells were preincubated (37°C, 18h) in medium only, at which time the Gr1 + cells expressed high level surface CXCR4, and then incubated for additional 18h with or without G-CSF (100 ng/mL). G-CSF reduced surface CXCR4 expression in Gr1 + cells that expressed highlevel surface CXCR4 (Fig. 1E ), but to a somewhat lower degree compared to freshly separated bone marrow cells. We compared the effect of removal of G-CSF or SDF-1 on CXCR4 surface levels in bone marrow Gr1 + cell. As expected, cell incubation for 40min with SDF-1 (400 ng/mL) reduced surface CXCR4, and cell washing followed by further incubation (2hr, 37°C in medium alone) was associated with considerable reconstitution of surface CXCR4, attributable to SDF-1-induced CXCR4 internalization and recycling to the cell surface ( Fig. 1F , lower panel). Cell incubation for 18h with G-CSF (30 ng/mL) reduced surface CXCR4, but in contrast to SDF-1, cell washing followed by further incubation (2hr, 37°C in medium alone) was not associated with
For personal use only. on . by guest www.bloodjournal.org From reconstitution of surface CXCR4 (Fig. 1F , upper panel). We purified Gr1 + cells (>95% purity) from mouse bone marrow cells by electronic sorting, and confirmed that G-CSF (100 ng/mL, 18h incubation) significantly reduces surface CXCR4 expression in this highly purified Gr1 + cell population (not shown).
In functional assays, we examined whether reduction of cell surface CXCR4 in Gr1 + cells was reflected by diminished responses to SDF-1, the CXCR4 specific ligand.
After pre-incubation (37°C, 18h) with medium only or medium with G-CSF (100 ng/mL) and washing, unfractionated bone marrow cell populations were tested for specific adhesion to SDF-1-coated wells (4 μg/mL) or buffer only over 30min at 37°C.
The proportion of Gr1 + cells that specifically adhered to SDF-1-coated wells was significantly (P<0.05) reduced after pre-incubation with G-CSF as opposed to medium alone ( Fig. 2A) . Although cell attachment in this assay system does not simply reflect SDF-1/CXCR4 interactions but depends on contributions by other molecules induced by CXCR4 activation 23 , these results provide evidence that G-CSF reduces functional CXCR4 levels in myeloid cells. Additionally, we found that the specific migration of Gr1 + cells in response to SDF-1 (60 and 300 ng/mL) was significantly reduced (P<0.05) after pre-incubation (37°C, 18h) with G-CSF (100 ng/mL) as opposed to medium alone (Fig. 2B ). These experiments demonstrated that G-CSF reduces surface CXCR4 expression in bone marrow myeloid cells and specific responses to SDF-1.
Analysis of the contribution of enzymatic cleavage to surface CXCR4 reduction by G-
CSF. G-CSF treatment promotes the accumulation of neutrophil-derived proteolytic enzymes, including neutrophil elastase, cathepsin-G, and metalloproteinase-9 (MMP-9)
in the bone marrow 17, 25 . Purified neutrophil elastase and cathepsin G can cleave 12 CXCR4 at the N-terminus 12, 20 . We tested supernatants of bone marrow cells cultured with G-CSF (100 ng/mL; 20 h incubation) for their ability to reduce cell surface CXCR4 levels in freshly isolated Gr1 + cells. Supernatants from G-CSF-treated cultures reduced significantly levels of surface CXCR4 in Gr1 + cells compared to supernatants from control cultures incubated (6h at 37°C) without G-CSF (Fig. 3A, left) . To distinguish between the two possibilities that this CXCR4 reduction was attributable to G-CSF in these supernatants (either human added to the cultures or murine from endogenous secretion) or to enzymes released in the culture supernatants as a consequence of G-CSF stimulation, we used G-CSF neutralizing antibodies. In the presence of G-CSF neutralizing antibodies to both human (5 μg/mL Peprotech Inc.) and mouse (3 μg/mL R&D Systems) G-CSF (Fig. 3A) , supernatants from G-CSF-activated bone marrow cultures did not reduce levels of surface CXCR4 in Gr1 + cells compared to control supernatants. We verified the effectiveness of G-CSF neutralization by measuring G-CSF bioactivity in the culture supernatants. Using the G-CSF-responsive NFS-60 cells, supernatants from G-CSF-activated bone marrow cultures induced significant proliferation compared to control supernatants, indicative of the presence of G-CSF.
However, addition of anti-human plus anti-mouse G-CSF neutralizing antibodies markedly reduced stimulation of NFS-60 cells by G-CSF-induced supernatants (Fig. 3B ).
These experiments provided evidence for a role of G-CSF as opposed to soluble products induced by G-CSF in the reduction of surface levels of CXCR4 in Gr1 + cells.
To examine further the potential contribution of neutrophil elastase and cathepsin G to the reduction of surface CXCR4 induced by G-CSF, we measured these enzymes in culture supernatants of bone marrow cells cultured in medium only or with G-CSF (100
For personal use only. on . by guest www.bloodjournal.org From 13 ng/mL) for 6-18 h. Mean neutrophil elastase levels in control supernatants (medium only) were 0.85±0.5 μg/mL (mean±SD; n=21) and in G-CSF-supplemented culture supernatants were 0.76±0.23 μg/mL (n=22) (P=0.576 vs. control). Mean cathepsin G levels in control supernatants were 0.25±0.32 μg/mL (n=21) and in G-CSF-supplemented culture supernatants were 0.17±0.21 μg/mL (n=22) (P=0.351 vs. control). In the absence of serum (DMEM with 0.2% bovine serum albumin), purified neutrophil elastase (40 μg/mL, 4 h at 37°C) reduced levels of surface CXCR4 in bone marrow Gr1 + cells (Fig. 3C ) and, unlike G-GSF, in lymphocytes ( Fig. 3D) as well, albeit to a lower degree.
The leukocyte elastase inhibitor (Elastase Inhibitor III (LEI 10 μM, added 10 min prior to addition of the enzyme) prevented this reduction (Fig. 3C, D) . Under these experimental conditions, surface CXCR4 reduction in myeloid and lymphoid cells was dependent upon the dose of neutrophil elastase (Fig. 3E) . However, unlike G-CSF, the enzyme was ineffective at reducing CXCR4 in the presence of 10% serum (not shown), 
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provide evidence that soluble products induced by G-CSF, including the enzymes neutrophil elastase, Cathepsin G, CD26/dipeptidylpeptidase IV and metalloproteinases, are not responsible for reducing surface CXCR4 levels in the current system, and rather point to a more direct role of G-CSF. . 4C ). This reduction was not attributable to unequal loading as reflected by membrane re-probing with actin antibodies (Fig. 4C) . Since there were no higher or lower molecular weight CXCR4-related bands specifically induced by G-CSF treatment during incubation, even after 18 h incubation (Fig. 4D) , these results provided evidence that G-CSF can reduce
G-CSF reduces
+ cells. Analysis of relative band intensities from 3-5 experiments revealed that CXCR4 levels are lower in the presence of G-CSF compared to medium alone (P<0.05 at time points 1h and 6h; P<0.1 at 3 and18 h) (Fig. 4E) .
G-CSF reduces CXCR4 synthesis in murine myeloid cells. We examined whether G-CSF reduces CXCR4 synthesis in this system. When bone marrow Gr1 + cells were cultured with Cycloheximide (CHX; 5 μg/mL), which inhibits protein synthesis, the appearance and size of the CXCR4-related bands was similar in cells cultured with or without G-CSF for 1 or 2h (Fig. 5A) . Noteworthy, in the presence of CHX with or without G-CSF, the 42kDa CXCR4 band was no longer visible ( Fig. 5A) , suggesting that this band may reflect newly synthesized CXCR4 protein. Moreover, the spontaneous increase of surface and cell-associated CXCR4 during incubation was blocked by CHX.
The observation that G-CSF no longer reduced the CXCR4 content in Gr1 + cells in the presence of CHX is consistent with G-CSF affecting CXCR4 synthesis.
We used quantitative RT-PCR to test whether G-CSF reduces CXCR4 mRNA levels in Gr1 + cells. Bone marrow Gr1 + cells were incubated (37°C, 30 min-18 hr) with our without G-CSF (100 ng/mL) and total RNA was extracted. As shown (Fig. 5B reflecting results from 3 experiments each performed in triplicate), the CXCR4 mRNA content was significantly (P<0.05, all time points) reduced in Gr1 + cells cultured with G-CSF as opposed to medium alone. These results demonstrate that G-CSF profoundly downregulates CXCR4 synthesis in bone marrow Gr1 + cells.
Reduced CXCR4 expression in murine myeloid cells following G-CSF treatment in vivo.
To test for the in vivo effects of G-CSF treatment on levels of CXCR4 in myeloid lineage cells, groups of 25 mice (C57/BL6, 6 weeks old) were treated systemically with G-CSF we purified Gr1 + cells from the bone marrow of mice treated for 5 days with G-CSF and from controls. By immunoblotting of total cell lysates, we found that levels of cellassociated CXCR4 were consistently lower in Gr1 + cells from G-CSF-treated mice compared to the untreated controls (Fig. 6A) . By contrast, levels of CXCR4 were similar in the Gr1 -bone marrow cell populations from G-CSF-treated and control mice (Fig. 6A ). This reduction in CXCR4 content exhibited by bone marrow Gr1 + cells from mice treated with G-CSF compared to controls was confirmed in two other independent experiments (Fig. 6B) . These results provide evidence that G-CSF mobilization of hematopoietic cells in mice is associated with a reduction of CXCR4 levels in bone marrow Gr1 + cells.
G-CSF reduces CXCR4 expression in human bone marrow myeloid cells.
Unfractionated cells from normal human bone marrows were incubated (1x10 6 cells/mL in DMEM culture medium supplemented with 10% FBS) at 37°C for 18h with or without G-CSF (1 and 100 ng/mL). G-CSF dose-dependently reduced surface CXCR4 levels in human CD33 + cells after 18h incubation (Fig. 7A) , as measured by double staining for CXCR4 (12G5 antibodies 27 ) and human CD33. By contrast, G-CSF did not substantially change surface CXCR4 levels in human CD33 -bone marrow cell populations after 18h incubation (Fig. 7B) . Kinetic analysis showed that levels of surface CXCR4 spontaneously increase in CD33 + cells during incubation in medium alone (Fig. 7C ). When present in these cultures, G-CSF (100 ng/mL) reduced surface 
CXCR4 levels in CD33
+ cells (Fig. 7C) , and this reduction was significant (P<0.05) beginning at the 4 hr time-point (Fig. 7D) .
We tested the effects of G-CSF on the CXCR4 content of human bone marrow CD33 + cells. To this end, we affinity-purified human bone marrow CD33 + cells (>85% pure). After 1.5 and 18h incubation 37°C with G-CSF (100 ng/mL), the purified CD33 + cells displayed a specific reduction in the intensities of CXCR4-related bands compared to cells cultured in medium alone (Fig. 7E) . These results provide evidence that G-CSF can reduce CXCR4 levels in human bone marrow myeloid cells.
Discussion
There is substantial evidence for a critical role of the SDF-1/CXCR4 axis in the retention of myeloid lineage cells to the bone marrow 2 . There is also evidence that disruption of the SDF-1/CXCR4 axis plays a role in the mobilization of myeloid lineage cells from the bone marrow to the peripheral circulation induced by G-CSF 1 , but the mechanisms underlying this disruption are incompletely known.
Here we show that G-CSF significantly and consistently down-regulates CXCR4 mRNA expression in bone marrow Gr1-expressing myeloid cells, and significantly reduces CXCR4 protein levels within and on the surface of murine and human bone marrow myeloid cells. When mice were mobilized with G-CSF, the Gr1 + myeloid cells from the bone marrow displayed reduced levels of CXCR4. These results support an important contribution of reduced CXCR4 expression to G-CSF-induced mobilization of myeloid lineage cells. Consistently with these results, AMD3100, a selective inhibitor of CXCR4 signaling and a mutant SDF-1β molecule, which binds CXCR4 and produces Prior to the current studies, a direct role of CXCR4 in mediating G-CSF mobilization was unclear. In one report, the amino terminus of CXCR4 was reported cleaved and the receptor inactive on human bone marrow and peripheral CD34 + hematopoietic progenitor cells following G-CSF mobilization 12 . Neutrophil elastase and cathepsin G were implicated in the cleavage 12 . However, the occurrence of Unlike CXCR4, several studies have documented a reductions of SDF-1 levels in the bone marrow following G-CSF treatment [12] [13] [14] , and a correlation was found between levels of SDF-1 reduction in the bone marrow and degree of hematopoietic progenitor cell mobilization 22 .
It was proposed that G-CSF indirectly causes SDF-1 degradation and inactivation through the peptidase enzymes neutrophil elastase, cathepsin-G or matrix metalloproteinase-9, which accumulate in the bone marrow during G-CSF treatment 12, 13, 17, 21 . However, mice genetically deficient of neutrophil elastase and cathepsin-G, matrix metalloproteinase-9 or dipetidylpeptidase I, an enzyme required for activation of several serine proteases, mobilized normally in response to G-CSF 16 . Cell surface-associated CD26/dipeptidyl peptidase IV was also proposed to contribute to G-CSF mobilization through cleavage and inactivation of SDF-1 34 , but there is no direct evidence of CD26 modulation during G-CSF mobilization, and CD26-null mice have no apparent defect in hematopoiesis 35 . However, in one study, CD26-null mice mobilized poorly in response to G-CSF 34 . The naturally occurring serine protease inhibitors serpina1 and serpina3 were reported down-regulated within the bone marrow during hematopoietic cell mobilization, raising the possibility that a shift in the balance between serine proteases and their natural inhibitors may be responsible for G-CSF-induced hematopoietic cell mobilization 36 . Recently, G-CSF was reported to indirectly reduce SDF-1 mRNA and protein levels in bone marrow cells, supporting a contribution of protease-independent mechanisms 22 .
We observed that G-CSF reduces CXCR4 expression in bone marrow myeloid cells but not in lymphocytes. Since myeloid cells express G-CSF receptors 37 and G-CSF rapidly reduces CXCR4 expression in highly purified Gr1 + cell populations, it is likely that in the current system G-CSF acts directly on the target myeloid cells.
Similarly, G-CSF was reported to directly downregulate ribosomal RNA synthesis in the myeloid 32D cells, a function that was mapped to the carboxyl-terminal domain of the For For 
